Showcasing Excellence: Bariatric Surgery for Type 2 Diabetes Mellitus Patients Requiring Insulin
We are proud to highlight our contribution to a high-impact publication in PLOS Medicine, an esteemed journal with an impact factor of 10.5. This underscores our commitment to excellence in clinical and economic research.
Read full article: link
The study, Bariatric Surgery for Patients with Type 2 Diabetes Mellitus Requiring Insulin: Clinical Outcome and Cost-Effectiveness Analyses, demonstrates the power of combining real-world data from the National Bariatric Surgical Registry (NBSR) with advanced health economic modeling to address a critical clinical and policy question.
The findings are groundbreaking:
- Bariatric surgery led to 67% insulin cessation rates at 1 year post-surgery, sustained over 4 years.
- The surgery was shown to be cost-saving over a 5-year horizon compared to best medical treatment (BMT), highlighting its economic viability for healthcare systems like the NHS.
- The study’s microsimulation model captured nuanced transitions between clinical states, providing robust insights into cost-effectiveness.
Relevance to Our Services
Our expertise aligns perfectly with the rigorous demands of such impactful studies, offering tailored services for healthcare evidence and decision-making:
- Advanced Health Economic Modeling
We specialize in state-transition models, microsimulations, and cost-effectiveness analyses like those in this study. These models are designed to meet the expectations of HTA bodies globally, ensuring decisions are based on the highest-quality evidence.
- Data Synthesis and Real-World Evidence (RWE)
By leveraging comprehensive datasets like the NBSR, we provide cutting-edge analyses that combine real-world evidence with robust statistical methods.
- Publication-Ready Deliverables
Our work is designed for impactful dissemination, helping our clients achieve publication in high-ranking journals. This amplifies the visibility and credibility of the research while influencing healthcare decision-makers.
- Global HTA and Market Access Expertise
Whether for the NHS, ICER, IQWiG, HAS, or other global HTA agencies, we ensure your economic models and clinical outcomes align with specific payer and regulatory requirements.
At our company, we specialize in providing comprehensive neural network services that can revolutionize your business. Whether you’re looking to enhance your data analysis capabilities, automate repetitive tasks, improve customer engagement, or optimize operational processes, our team of experts is here to help you leverage the full potential of neural networks.
Data lies at the heart of neural networks, and our services start with understanding your unique data landscape. We work closely with you to identify and collect relevant data sources, ensuring that your neural network models are built on a solid foundation. Our data scientists employ cutting-edge techniques to preprocess and clean the data, making it ready for training the neural network models.
Why Choose Us?
Let us help you achieve impactful outcomes like these through robust evidence generation and value demonstration strategies. Together, we can advance the field of healthcare innovation.
- Proven Track Record: Our work has been recognized in top-tier journals like PLOS Medicine.
- Cross-Disciplinary Expertise: Bridging clinical, economic, and statistical disciplines to deliver comprehensive solutions.
- Tailored Solutions: Custom models and analyses that align with your specific therapeutic area and market access goals.
- Impactful Value Demonstration: Demonstrating the cost-effectiveness and real-world outcomes of your interventions to stakeholders and decision-makers.